Tel-Mond, Israel

Tal Atarot

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nutrinia, Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tal Atarot. Retrieved from https://idiyas.com/inventor/tal-atarot-re3f9vgm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tal Atarot: Innovator in Gastric Emptying Solutions

Introduction

Tal Atarot is an accomplished inventor based in Tel-Mond, Israel. He has made significant contributions to the field of medical science, particularly in the area of gastric disorders. His innovative approach focuses on the use of insulin to promote gastric emptying, which addresses a critical need in treating patients with delayed gastric emptying.

Latest Patents

Tal Atarot holds 1 patent for his groundbreaking work titled "Use of insulin for promoting gastric emptying." This patent outlines methods for utilizing insulin or a composition containing insulin to enhance gastric emptying and treat related gastric disorders. The methods described in the patent emphasize enteral administration, providing a novel approach to managing these conditions.

Career Highlights

Throughout his career, Tal has worked with notable companies in the pharmaceutical and medical sectors. He has been associated with Nutrinia Ltd. and Elgan Pharma Ltd., where he has contributed his expertise in developing innovative solutions for gastric health.

Collaborations

Tal has collaborated with various professionals in his field, including Michal Olshansky, to further advance his research and innovations.

Conclusion

Tal Atarot's work in the field of gastric emptying represents a significant advancement in medical science. His innovative use of insulin offers new hope for patients suffering from gastric disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…